Elsevier

Placenta

Volume 26, Issue 10, November 2005, Pages 735-746
Placenta

Nicotinic acetylcholine receptors in rat and human placenta

https://doi.org/10.1016/j.placenta.2004.10.009Get rights and content

Smoking during pregnancy causes low birth weight, premature delivery, neonatal morbidity, and mortality. Nicotine is a main pathogenic compound of cigarette smoke, and depresses active amino-acid uptake by human placental villi. It binds to the acetylcholine binding site of the α-subunits of nicotinic acetylcholine receptors (nAChR). Eight different neuronal nAChR α-subunits have been identified in mammals. Here, we investigated their localisation and distribution in the human and rat placenta by RT-PCR and immunofluorescence. The mRNAs of all α-subunits are expressed in the human and rat placenta. Immunohistochemically, subunits α2–5, α7, α9 and α10 are localised in different combinations in rat cytotrophoblast, human and rat syncytiotrophoblast, vascular smooth muscle cells, endothelial cells, Hofbauer cells, human amnion epithelium and rat visceral yolk sac epithelium. Thus, all human and rat placental cell types exhibit receptor subunits with binding sites for the endogenous ligand ACh and nicotine. ACh is suggested to be an important placental signalling molecule that, through stimulation of nAChR, controls the uptake of nutrients, blood flow and fluid volume in placental vessels, and the vascularisation during placental development. Chronic stimulation of nAChR by nicotine might result in unbalanced receptor activation or functional desensitisation followed by the known pathological effects of smoking.

Introduction

Smoking during pregnancy causes low birth weight, premature delivery, neonatal morbidity, mortality [1], [2], and increases the risk of behavioral problems, attention deficits, hyperactivity and learning disabilities, sudden infant death syndrome and nicotine dependence later in life ([3], [4], for review). Nicotine is the component of tobacco smoke that causes addiction [5]. It is considered to be a main pathogenic compound of cigarette smoke [6], and depresses active amino-acid uptake by human placental villi [7]. Part of this depression (10–16%) is irreversible [7].

Nicotine stimulates nicotinic acetylcholine receptors (nAChR) by binding at the acetylcholine binding site of the nAChR α-subunits [8]. The nAChR restricted to the motor endplate of skeletal muscle are distinguished from receptors of the neuronal type. The nAChR of the motor endplate are Na+-permeable heteropentamers, composed of two α-, one β-, γ- or ɛ- and δ-subunit each. Receptors of the neuronal type are permeable to mono- and divalent cations. They are heteromers composed of two α-subunits and three β-subunits, homopentamers of five α-subunits (e.g. α7, α9) or α-heteropentamers (e.g. α9/10) [9], [10], [11], [12]. Until recently, 10 different α-subunits and four different β-subunits have been identified. The α1 and β1 subunits are found exclusively at the motor endplate. Receptors of the neuronal type consist of α2–10 and β2–4 subunits [10], [13], [14], [15], [16]. Among these, the α8 subunit has only been found in chick [17]. The composition of subunits in the receptor determines ligand specificity, ligand affinity, cation permeability and channel kinetics [18], e.g. α-homomers and α-heteromers have an increased Ca2+-permeability [10], [12], [19], [20]. Data on the detailed expression and distribution of the individual nAChR α-subunits in the placenta are required as a basis for a better understanding of both the endogenous placental cholinergic signalling pathways and their perturbation by nicotine as it occurs during maternal smoking. In this study, we investigated the presence, localisation and distribution of the nAChR α-subunits in placenta utilizing RT-PCR and immunofluorescence. In addition to the human placenta, we also studied rat material since this species often serves as experimental model, and similarities or dissimilarities to the situation found in human are of interest when experimental data are to be interpreted.

Section snippets

RT-PCR

Placenta and visceral yolk sac epithelium from Wistar rats (Harlan Winkelmann, Borchem, Germany) at gestational days 15 (n = 1), 18 (n = 2) and 21 (n = 2) and human term placenta (n = 3) were used for mRNA isolation with Oligotex (Qiagen, Hilden, Germany). RNA was reverse-transcribed with superscript RNase H reverse transcriptase (200 U/100–500 ng mRNA, Gibco-BRL, Karlsruhe, Germany) for 50 min at 42 °C. The cDNAs (1 μl/onset) were amplified with 12.5 pM gene specific primer (rat: Table 1, human: Table 2;

Rat placenta

All mammalian nAChR α-subunits (α2–7 and α9–10) mRNAs were detected by RT-PCR in rat visceral yolk sac epithelium (Figure 1A) and placenta without yolk sac epithelium (Figure 2A) of gestational days 15, 18 and 21.

Placenta and visceral yolk sac epithelium of gestational day 21 were used for immunohistochemical analysis. Localisation of the α2 subunit was conducted using a polyclonal goat antiserum directed against the carboxy terminus which is also shared with the α4-subunit. This

Discussion

This study is the first detecting nAChR in human and rat placenta by RT-PCR and immunofluorescence. The mammalian neuronal nAChR α-subunits have a widespread distribution in human and rat placenta. The α-subunits of nAChR exhibit the ligand binding site for the endogenous ligand ACh that also binds the toxin, nicotine. Endogenous ACh is synthesised in the syncytiotrophoblast and released into both the maternal and fetal circulation, where it is essential as placental signalling molecule [26],

Acknowledgements

Monoclonal antibody 54.1 was obtained by permission from Dr. A.J. Jesaitis, Department of Microbiology, Montana State University. We thank Mr M. Bodenbenner, Ms U. Butz-Schiller, Ms K. Michael and Ms S. Tasch for skilful technical assistance. This study was supported by grants from the Hessisches Ministerium für Wissenschaft und Kunst (to KSL), and by the DFG (GK 534, to WK, DB, and Li1051/1-1).

References (64)

  • B.V.R. Sastry

    Human placental cholinergic system

    Biochem Pharmacol

    (1997)
  • A. Kuryatov et al.

    Human alpha6 AChR subtypes: subunit composition, assembly, and pharmacological responses

    Neuropharmacology

    (2000)
  • A.B. Elgoyhen et al.

    Alpha 9: an acetylcholine receptor with novel pharmacological properties expressed in rat cochlear hair cells

    Cell

    (1994)
  • I. Wessler et al.

    Non-neuronal acetylcholine, a locally acting molecule, widely distributed in biological systems: expression and function in humans

    Pharmacol Ther

    (1998)
  • B.M. Conti-Fine et al.

    Neuronal nicotinic receptors in non-neuronal cells: new mediators of tobacco toxicity?

    Eur J Pharmacol

    (2000)
  • S.C. Birnbaum et al.

    Nicotine- or epinephrine-induced uteroplacental vasoconstriction and fetal growth in the rat

    Toxicology

    (1994)
  • V.T. Nguyen et al.

    Novel human α9 acetylcholine receptor regulating keratinocyte adhesion is targeted by pemphigus vulgaris autoimmunity

    Am J Pathol

    (2000)
  • K.S. Lips et al.

    Coexpression of α9 and α10 nicotinic acetylcholine receptors in rat dorsal root ganglion neurons

    Neuroscience

    (2002)
  • M.S. Kramer

    Intrauterine growth and gestational duration determinants

    Pediatrics

    (1987)
  • R. Niaura et al.

    Maternal transmission of nicotinic dependence: psychiatric, neurocognitive and prenatal factors

    Am J Addict

    (2001)
  • B.V.R. Sastry

    Placental toxicology: tobacco smoke, abused drugs, multiple chemical interactions and placental function

    Reprod Fertil Dev

    (1991)
  • A.B. Elgoyhen et al.

    α10: a determinant of nicotinic cholinergic receptor function in mammalian vestibular and cochlear mechanosensory hair cells

    Proc Natl Acad Sci

    (2001)
  • N. Le Novere et al.

    The diversity of subunit composition in nAChRs: evolutionary origins, physiologic and pharmacologic consequences

    J Neurobiol

    (2002)
  • F. Sgard et al.

    A novel human nicotinic receptor subunit, alpha10, that confers functionality to the alpha9-subunit

    Mol Pharmacol

    (2002)
  • D.S. McGehee et al.

    Physiological diversity of nicotinic acetylcholine receptors expressed in vertebrate neurons

    Annu Rev Physiol

    (1995)
  • J. Lindstrom

    Neuronal nicotinic acetylcholine receptors

    Ion Channels

    (1996)
  • S.S. Kirough et al.

    Rat nicotinic ACh receptor α7 and β2 co-assemble to form functional heteromeric nicotinic receptor channels

    J Physiol

    (2002)
  • J. Lindstrom

    The structures of neuronal nicotinic receptors

  • P. Buisson et al.

    Neuronal nicotinic acetylcholine receptors: from biophysical properties to human diseases

  • A.M. Duijvestijn et al.

    Antibodies defining rat endothelial cells: RECA-1, a pan-endothelial cell-specific monoclonal antibody

    Lab Invest

    (1992)
  • M. Dvorakova et al.

    Rat sensory neurons contain cytochrome b558 large subunit immunoreactivity

    NeuroReport

    (1999)
  • J. Metz et al.

    Ultrastructure of the labyrinth in the rat full-term placenta

    Anat Embryol

    (1976)
  • Cited by (99)

    • Polycyclic aromatic hydrocarbons (PAHs) may explain the paradoxical effects of cigarette use on preeclampsia (PE)

      2022, Toxicology
      Citation Excerpt :

      The role of these receptors has been well studied in the brain, but they are also found in non-neural tissue including the placenta (Zoli et al., 2018). More specifically, immunofluorescence techniques have shown nAChR localized to the syncytium and cytotrophoblasts in terminal villi as well as in mesenchymal and Hofbauer cells, placental villous macrophages of fetal origin associated with regulatory and anti-inflammatory functions (Zulu et al., 2019; Lips et al., 2005). NAChRs are involved in many cellular processes including proliferation, adhesion and migration, all of which are important for placental development (Suter and Aagaard, 2020).

    View all citing articles on Scopus
    View full text